Stay updated on XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial
Sign up to get notified when there's something new on the XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial page.
Latest updates to the XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision: v3.3.2 replaces the previous v3.2.0 version.SummaryDifference0.1%
- Check28 days agoChange DetectedThe generic government funding/operating status notice was removed from the page, while the study details remain unchanged.SummaryDifference0.4%
- Check42 days agoChange DetectedNo additions or deletions to the page's core content are evident; the study's title, conditions, design, and locations appear unchanged. Any observed differences are likely minor formatting or layout adjustments rather than substantive content changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check71 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference3%
- Check78 days agoChange DetectedUpdate: version from v3.0.2 to v3.1.0, indicating a new release.SummaryDifference0.1%
- Check93 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2. The 'Back to Top' link was removed.SummaryDifference0.2%
Stay in the know with updates to XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial page.